BDBM689074 (S)-N-((1-Aminoisoquinolin-6- yl)methyl)-6-(6-chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3]oxazine- 4,3'-pyrrolidin]-1'-yl)pyrazine-2- carboxamide::US20240190892, Example 32

SMILES Nc1nccc2cc(CNC(=O)c3cncc(n3)N3CC[C@]4(C3)OC(=O)Nc3ccc(Cl)c(F)c43)ccc12

InChI Key InChIKey=SXDOHQWEEIWSEE-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 689074   

TargetPlasma kallikrein(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM689074(US20240190892, Example 32 | (S)-N-((1-Aminoisoquin...)
Affinity DataIC50: 19nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of plasma kallikrein can be determined using a relevant purified serine prot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM689074(US20240190892, Example 32 | (S)-N-((1-Aminoisoquin...)
Affinity DataIC50: 1.00E+4nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation factor XIa can be determined using a relevant purified serine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent